Revvity
Company Snapshot
Company Overview
Revvity is a health science tools and diagnostics company headquartered in Waltham, Massachusetts, U.S. It operates in two segments: life sciences and diagnostics, and markets its products and services in more than 160 countries.
In the protein labeling market, Revvity participates primarily through life sciences reagents and assay technologies used to label, detect, and quantify proteins in immunoassays, cell-based assays, and imaging workflows. Its portfolio includes fluorophore-conjugated and enzyme-conjugated antibodies, as well as related buffers and solutions, along with homogeneous assay platforms such as HTRF, AlphaLISA, AlphaPlex, and DELFIA, which are commonly used for protein detection and signal readouts in research assays.
Financial Highlights (FY 2025)
This information is available for BCC Research members only.
Company's Business Segments
- Life Sciences : Sales of instruments, reagents, software, subscriptions, detection and imaging technologies, extended warranties, training and services
- Diagnostics : Sales of instruments, solutions, consumables, reagents, and services
Applications/End User Industries
- Hospitals
- Medical Labs
- Clinicians
- Medical Research Professionals
- Research Institutions
- Pharmaceutical Companies